LARIMAR THERAPEUTICS, INC. (LRMR) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $1.00K; Common Stock, Value, IssuedUSD $103.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $624.52M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $1.00K; Common Stock, Value, IssuedUSD $103.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $622.37M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $83.00K; Additional Paid in Capital, Common StockUSD $512.78M; Additional Paid in CapitalUSD $512.78M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $86.00K; Additional Paid in Capital, Common StockUSD $511.22M; Additional Paid in CapitalUSD (m).
LARIMAR THERAPEUTICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K | $103.00K | (m) | $624.52M | $-12.00K | $-497.23M | $127.38M | 3 month · $2.15M |
| 2026-03-31 | $1.00K | $103.00K | (m) | $622.37M | $6.00K | $-464.44M | $158.03M | 3 month · $1.98M |
| 2025-12-31 | (m) | $83.00K | $512.78M | $512.78M | $54.00K | $-434.83M | $78.08M | 12 month · $7.00M |
| 2025-09-30 | (m) | $86.00K | $511.22M | (m) | $66.00K | $-372.33M | $139.04M | 3 month · $1.78M |
| 2025-06-30 | (m) | $64.00K | $444.42M | (m) | $-9.00K | $-324.62M | $119.85M | 3 month · $1.83M |
| 2025-03-31 | (m) | $64.00K | $442.59M | (m) | $54.00K | $-298.44M | $144.27M | 3 month · $1.83M |
| 2024-12-31 | (m) | $64.00K | $440.76M | (m) | $148.00K | $-269.16M | $171.81M | 12 month · $8.80M |
| 2024-09-30 | (m) | $64.00K | $438.31M | (m) | $358.00K | $-240.33M | $198.40M | 3 month · $1.96M |
| 2024-06-30 | (m) | $64.00K | $436.32M | (m) | $-150.00K | $-224.84M | $211.40M | 3 month · $2.30M |
| 2024-03-31 | (m) | $64.00K | $434.01M | (m) | $-25.00K | $-203.21M | $230.84M | 3 month · $2.13M |
| 2023-12-31 | (m) | $43.00K | $270.15M | (m) | $81.00K | $-188.55M | $81.72M | 12 month · $7.62M |
| 2023-09-30 | $0.00 | $43.00K | $268.22M | (m) | $7.00K | $-175.56M | $92.71M | 3 month · $1.82M |
| 2023-06-30 | $0.00 | $43.00K | $266.37M | (m) | $12.00K | $-166.50M | $99.93M | 3 month · $2.04M |
| 2023-03-31 | $0.00 | $43.00K | $264.33M | (m) | (m) | $-158.13M | $106.24M | 3 month · $1.83M |
| 2022-12-31 | $0.00 | $43.00K | $262.50M | (m) | $-31.00K | $-151.60M | $110.90M | 12 month · $6.62M |
| 2022-09-30 | $0.00 | $43.00K | $260.84M | (m) | $-40.00K | $-142.18M | $118.66M | 3 month · $1.67M |
| 2022-06-30 | $0.00 | $18.00K | $183.96M | (m) | $-57.00K | $-133.86M | $50.06M | 3 month · $1.68M |
| 2022-03-31 | (m) | $18.00K | $182.28M | (m) | (m) | $-125.19M | $57.10M | 3 month · $1.64M |
| 2021-12-31 | $0.00 | $18.00K | $180.65M | (m) | (m) | $-116.25M | $64.41M | 12 month · $5.47M |
| 2021-09-30 | (m) | $18.00K | $179.16M | (m) | (m) | $-107.12M | $72.07M | 3 month · $1.46M |
| 2021-06-30 | (m) | $15.00K | $157.82M | (m) | $1.00K | $-90.31M | $67.53M | 3 month · $1.35M |
| 2021-03-31 | (m) | $15.00K | $156.47M | (m) | $1.00K | $-77.70M | $78.78M | 3 month · $1.18M |
| 2020-12-31 | (m) | $15.00K | $155.29M | (m) | $1.00K | $-65.61M | $89.69M | 12 month · $2.16M |
| 2020-09-30 | (m) | $15.00K | $154.04M | (m) | $-2.00K | $-51.41M | $102.64M | 3 month · $370.00K |
| 2020-06-30 | (m) | $15.00K | $153.67M | (m) | $-3.00K | $-41.14M | $112.54M | 3 month · $752.00K |
| 2020-03-31 | (m) | $37.00K | $450.62M | (m) | $31.00K | $-399.95M | $2.26M | 3 month · $29.00K |
| 2019-12-31 | (m) | $6.00K | $22.43M | (m) | $35.00K | $-23.13M | $-694.00K | 12 month · $129.00K |
| 2019-09-30 | (m) | $37.00K | $448.90M | (m) | $41.00K | $-389.10M | $1.90M | 3 month · $33.00K |
| 2019-06-30 | (m) | $37.00K | $448.26M | (m) | $30.00K | $-376.19M | $543.00K | 3 month · $33.00K |
| 2019-03-31 | (m) | $37.00K | $446.38M | (m) | $1.00K | $-364.06M | $1.22M | 3 month · $34.00K |
| 2018-12-31 | (m) | $37.00K | $444.21M | (m) | $-33.00K | $-350.94M | $2.91M | 12 month · $9.63M |
| 2018-09-30 | (m) | $37.00K | $440.30M | (m) | $-28.00K | $-336.38M | $103.94M | 3 month · $2.20M |
| 2018-06-30 | (m) | $28.00K | $373.31M | (m) | $-6.00K | $-321.31M | $52.02M | 3 month · $2.67M |
| 2018-03-31 | (m) | $28.00K | $370.55M | (m) | $-49.00K | $-305.53M | $65.00M | 3 month · $2.47M |
| 2017-12-31 | (m) | $27.00K | $367.82M | (m) | $-58.00K | $-289.58M | $78.22M | 12 month · $8.30M |
| 2017-09-30 | (m) | $27.00K | $365.72M | (m) | $-28.00K | $-276.49M | $89.23M | (m) |
| 2017-06-30 | (m) | $27.00K | $363.55M | (m) | $-41.00K | $-263.91M | $99.63M | (m) |
| 2017-03-31 | (m) | $27.00K | $361.37M | (m) | $-63.00K | $-250.56M | $110.77M | (m) |
| 2016-12-31 | (m) | $27.00K | $359.33M | (m) | $-80.00K | $-237.55M | $121.73M | 12 month · $10.11M |
| 2016-09-30 | (m) | $27.00K | $357.32M | (m) | $-66.00K | $-227.11M | $130.17M | (m) |
| 2016-06-30 | (m) | $27.00K | $354.66M | (m) | $-14.00K | $-212.44M | $142.24M | (m) |
| 2016-03-31 | (m) | $27.00K | $351.81M | (m) | $1.00K | $-197.41M | $154.43M | (m) |
| 2015-12-31 | (m) | $27.00K | $348.96M | (m) | $-207.00K | $-179.67M | $169.11M | 12 month · $8.58M |
| 2015-09-30 | (m) | $27.00K | $346.20M | (m) | $-32.00K | $-156.50M | $189.70M | (m) |
| 2015-06-30 | (m) | $27.00K | $342.84M | (m) | $-60.00K | $-136.61M | $206.19M | (m) |
| 2015-03-31 | (m) | $27.00K | $340.54M | (m) | $-39.00K | $-118.86M | $221.67M | (m) |
| 2014-12-31 | (m) | $23.00K | $209.84M | (m) | $-35.00K | $-105.39M | $104.44M | 12 month · $1.55M |
| 2014-09-30 | (m) | $23.00K | $205.63M | (m) | (m) | $-94.45M | $111.20M | (m) |
| 2014-06-30 | (m) | $23.00K | $205.16M | (m) | (m) | $-79.77M | $125.42M | (m) |
| 2013-12-31 | (m) | $1.00K | $332.00K | (m) | (m) | $-68.91M | $-68.57M | 12 month · $395.00K |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-54.73M | 12 month · $121.00K |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-40.92M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |